KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001860131-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | May 27, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
12,239
Total Value
$59,955.49
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | May 22, 2026 | Exercise/Conversion | 5,000 | โ | โ | 152,499 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | May 26, 2026 | Sale | 2,239 | $26.78 | $59,955.49 | 150,260 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Restricted Stock Unit | Derivative | May 22, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 40,000 | Direct | โ | View Details |